ACTIVE HALF-LIFE
12-36 hours
CLASSIFICATION
Peptide Hormone
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
IBSA
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Menopausal Gonadotropin
,
Merional 150IU, commonly referred to as hMG, is utilized to address infertility in women and is also known as Menotropin. This hormone-based medication promotes egg production in women experiencing ovarian failure. The Merional 150IU Injection is derived from the urine of postmenopausal women, which contains elevated levels of follicle stimulating hormone (FSH), lutropin hormone (LH), and other gonadotropins. The injection is administered intramuscularly.
Potential side effects of Merional 150IU Injection include headaches, mood changes, fatigue, weight gain, localized swelling at the injection site, breast enlargement, and tenderness. Another prevalent effect is abdominal pain resulting from ovarian hyperstimulation syndrome (OHSS), which occurs when excessive egg production leads to swollen ovaries. Additionally, there is a risk of conceiving twins if this was not the initial intention. It is important to consult your physician before starting this medication, particularly if you have any of the following conditions:
Dosage may vary per individual and is tailored to the specific needs of each patient. Ideally, to increase the chances of pregnancy, it is recommended to attempt conception within 12 to 36 hours after the Merional 150IU Injection. Should the initial treatment cycle not succeed, it is advisable to reassess the situation. If ovulation does not occur after three cycles, consider discussing further options with your doctor regarding the use of Merional 150IU.